Genprex, Inc. — Director's Dealing 2020

Jul 28, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Genprex, Inc. (GNPX)
CIK: 0001595248
Period of Report: 2020-07-24

Reporting Person: Moreno Toscano Jose Antonio (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-07-24	Stock Option (right to buy)	$3.69	A	42068	Acquired	2030-07-24	Common Stock (42068)	Direct

Footnotes

F1: Equal to the greater of (a) the fair market value of a share of common stock on June 18, 2020, the date on which the option grant was to be made under the Genprex, Inc. Outside Director Compensation Policy and (b) the fair market value of a share of common stock on July 24, 2020, the date on which the option grant was made.

F2: One hundred percent (100%) of the Shares subject to the Option shall vest upon the earlier of (a) the one (1) year anniversary of June 18, 2020 and (b) the day prior to the Company's next annual meeting of the Company's stockholders occurring after the grant date, provided that the Optionee continues to serve as a Service Provider (as defined in the Genprex, Inc. 2018 Equity Incentive Plan) through the applicable vesting date.